[Proglumetacin: a flexible and safe anti-inflammatory agent for effective clinical practice].
Thirty-six patients with orthopedic disorders were treated with proglumetacin. Therapeutic efficacy was rated as good or very good in 97% of patients. The overall mean of symptoms decreased by 75% in patients with acute diseases and by 61% in patients with chronic diseases. Tolerance was very good in all patients but one (97%).
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007210:Indoleacetic Acids / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*
D007210:Indoleacetic Acids; C019541:proglumetacin
La proglumetacina: un antiinfiammatorio flessibile e sicuro per una pratica clinica efficace.